DP1 DA026182-01/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

Gill VS, Lima VD, Zhang W, Wynhoven B, Yip B, Hogg RS, Montaner JS, Harrigan PR. Gill VS, et al. Clin Infect Dis. 2010 Jan 1;50(1):98-105. doi: 10.1086/648729. Clin Infect Dis. 2010. PMID: 19951169 Free PMC article.

Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.

Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, Montaner JS. Lima VD, et al. J Acquir Immune Defic Syndr. 2010 Dec;55(4):460-5. doi: 10.1097/QAI.0b013e3181f2ac87. J Acquir Immune Defic Syndr. 2010. PMID: 20838225 Free PMC article.

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P. Montaner JS, et al. Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16. Lancet. 2010. PMID: 20638713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters